Skip to content
healthcare.dev

LAMIVUDINE

NDC 60505-3251, lamivudine, tablet, film coated, from Apotex Corp..

Product NDC
60505-3251
Status
Listed
Labeler
Apotex Corp.
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA091606
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/60505-3251 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LAMIVUDINE150 mg/1

Pharmacologic classes

Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Nucleoside Reverse Transcriptase Inhibitors [MoA]

Package NDCNDC-11Package
60505-3251-66050532510660 TABLET, FILM COATED in 1 BOTTLE (60505-3251-6)
60505-3251-8605053251081000 TABLET, FILM COATED in 1 BOTTLE (60505-3251-8)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/34c02bcc-d6ff-99d4-8e6a-4a91908adca8
  • NADAC price for package 60505325106

    GET /v1/drugs/nadac/60505325106

Use it

Look up 60505-3251 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/60505-3251 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 60505-3251. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.